Jun Ishiwa is the Head of the business unit for Haemophilia at CSL Behring, where they lead initiatives in the life sciences sector. They have held various significant roles in pharmaceutical marketing and clinical research across several prominent companies, including Kyowa Hakko, Schering-Plough Japan, Daiichi Sankyo, and Mundipharma. Ishiwa's educational background includes an MSc in Pharmacology from Tokyo University of Pharmacy and Life Sciences and they are currently pursuing an MBA.
Location
Japan
This person is not in the org chart
This person is not in any teams
This person is not in any offices